A detailed history of Shell Asset Management CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Shell Asset Management CO holds 34,983 shares of EW stock, worth $2.29 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
34,983
Previous 39,676 11.83%
Holding current value
$2.29 Million
Previous $3.79 Million 14.77%
% of portfolio
0.15%
Previous 0.17%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 31, 2024

SELL
$72.54 - $95.56 $340,430 - $448,463
-4,693 Reduced 11.83%
34,983 $3.23 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $750,353 - $988,472
-10,344 Reduced 20.68%
39,676 $3.79 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $805,685 - $1.02 Million
-13,056 Reduced 20.7%
50,020 $3.81 Million
Q3 2023

Nov 08, 2023

SELL
$69.28 - $93.38 $85,491 - $115,230
-1,234 Reduced 1.92%
63,076 $4.37 Million
Q2 2023

Jul 28, 2023

SELL
$81.41 - $94.33 $681,890 - $790,108
-8,376 Reduced 11.52%
64,310 $6.07 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $97,280 - $110,708
1,310 Added 1.84%
72,686 $6.01 Million
Q4 2022

Feb 07, 2023

BUY
$68.3 - $87.44 $1.24 Million - $1.58 Million
18,103 Added 33.98%
71,376 $5.33 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $1.09 Million - $1.42 Million
-13,254 Reduced 19.92%
53,273 $4.4 Million
Q2 2022

Aug 09, 2022

BUY
$86.5 - $128.27 $80,531 - $119,419
931 Added 1.42%
66,527 $6.33 Million
Q1 2022

May 04, 2022

SELL
$101.96 - $128.34 $2.14 Million - $2.7 Million
-21,000 Reduced 24.25%
65,596 $7.72 Million
Q4 2021

Feb 09, 2022

BUY
$106.37 - $130.68 $877,020 - $1.08 Million
8,245 Added 10.52%
86,596 $11.2 Million
Q3 2021

Nov 04, 2021

BUY
$102.91 - $122.75 $158,069 - $188,544
1,536 Added 2.0%
78,351 $8.87 Million
Q2 2021

Aug 12, 2021

SELL
$83.84 - $104.76 $307,273 - $383,945
-3,665 Reduced 4.55%
76,815 $7.96 Million
Q1 2021

May 10, 2021

BUY
$78.68 - $90.67 $319,047 - $367,666
4,055 Added 5.31%
80,480 $6.73 Million
Q4 2020

Feb 16, 2021

BUY
$71.69 - $91.23 $1.09 Million - $1.39 Million
15,185 Added 24.8%
76,425 $6.97 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $812,192 - $1.06 Million
-12,088 Reduced 16.48%
61,240 $4.89 Million
Q2 2020

Aug 10, 2020

BUY
$57.54 - $76.95 $2.42 Million - $3.24 Million
42,044 Added 134.39%
73,328 $5.07 Million
Q1 2020

May 11, 2020

SELL
$52.41 - $81.0 $189,514 - $292,896
-3,616 Reduced 10.36%
31,284 $5.9 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $580,196 - $664,272
8,092 Added 30.19%
34,900 $8.14 Million
Q3 2019

Nov 12, 2019

SELL
$61.55 - $75.43 $49,363 - $60,494
-802 Reduced 2.9%
26,808 $5.9 Million
Q2 2019

Aug 12, 2019

BUY
$55.74 - $64.41 $212,871 - $245,981
3,819 Added 16.05%
27,610 $5.1 Million
Q4 2018

Feb 13, 2019

SELL
$46.41 - $56.94 $611,405 - $750,127
-13,174 Reduced 35.64%
23,791 $3.64 Million
Q3 2018

Nov 13, 2018

BUY
$45.7 - $58.03 $154,009 - $195,561
3,370 Added 10.03%
36,965 $6.44 Million
Q2 2018

Aug 10, 2018

SELL
$42.45 - $51.3 $14,645 - $17,698
-345 Reduced 1.02%
33,595 $4.89 Million
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $9,297 - $11,862
250 Added 0.74%
33,940 $4.74 Million
Q4 2017

Feb 09, 2018

BUY
$33.79 - $39.39 $149,892 - $174,734
4,436 Added 15.16%
33,690 $3.8 Million
Q3 2017

Oct 20, 2017

BUY
$36.29 - $38.83 $1.06 Million - $1.14 Million
29,254 New
29,254 $3.2 Million
Q3 2017

Oct 18, 2017

SELL
$36.29 - $38.83 $700,977 - $750,040
-19,316 Closed
0 $0
Q2 2017

Oct 20, 2017

SELL
N/A
-20,216 Reduced 51.14%
19,316 $2.28 Million
Q1 2017

Oct 20, 2017

SELL
N/A
-9,864 Reduced 19.97%
39,532 $3.72 Million
Q4 2016

Oct 20, 2017

BUY
N/A
1,842 Added 3.87%
49,396 $4.63 Million
Q3 2016

Oct 20, 2017

BUY
N/A
47,554
47,554 $5.73 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Shell Asset Management CO Portfolio

Follow Shell Asset Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.